抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產品編號 | 圖片 | 產品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
Glumetinib，98% | ?C21H17N9O2S | |||
|
|
|||||
|
SRI 31215 TFA，≥98% | C27H34F3N5O3 | |||
|
|
|||||
|
CS-2800，98% | C20H21FN6O | |||
|
|
|||||
|
Ehp-inhibitor，98% | C17H13N5O | |||
|
|
|||||
|
SAR125844，≥96% | C25H23FN8O2S2 | |||
|
|
|||||
|
RU-301，98% | C??H??F?N?O?S | |||
|
|
|||||
|
NVP-BHG712 isomer，98% | C26H20F3N7O | |||
|
|
|||||
|
CSF1R-IN-1，98% | C25H20F3N5O2 | |||
|
|
|||||
|
Dihexa，98% | C27H44N4O5 | |||
|
|
|||||
|
ALW-II-41-27，99% | C32H32F3N5O2S | |||
|
|
|||||
|
RU-302，98% | C24H24F3N3O2S | |||
|
|
|||||
|
BAY-474，98% | C17H15N5 | |||
|
|
|||||
